1. 4 Immune response evaluation to curative conventional therapy – The IRECT trial. Issue 5 (May 2015) Authors: Atanackovic, D.; Lütkens, T.; Lotfi, R.; Mytilineos, J.; Schuler, P.; Veit, J.; Hoffmann, T.K. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4 Immune response evaluation to curative conventional therapy – The IRECT trial. Issue 5 (May 2015) Authors: Laban, S.; Atanackovic, D.; Lütkens, T.; Lotfi, R.; Mytilineos, J.; Schuler, P.; Veit, J.; Hoffmann, T.K. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4 Immune response evaluation to curative conventional therapy – The IRECT trial. Issue 5 (May 2015) Authors: Laban, S.; Atanackovic, D.; Lütkens, T.; Lotfi, R.; Mytilineos, J.; Schuler, P.; Veit, J.; Hoffmann, T.K. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 49 Identification of kallikrein-related peptidase 6 in primary mucosal malignant melanoma of the head and neck. Issue 5 (May 2015) Authors: , .; Veit, J.; Knopf, A.; Bergmann, C.; Hoffmann, T.K.; Plinkert, P.K.; Koffler, J.; Heß, J. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 49 Identification of kallikrein-related peptidase 6 in primary mucosal malignant melanoma of the head and neck. Issue 5 (May 2015) Authors: Thierauf, J.; Veit, J.; Knopf, A.; Bergmann, C.; Hoffmann, T.K.; Plinkert, P.K.; Koffler, J.; Heß, J. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 49 Identification of kallikrein-related peptidase 6 in primary mucosal malignant melanoma of the head and neck. Issue 5 (May 2015) Authors: Thierauf, J.; Veit, J.; Knopf, A.; Bergmann, C.; Hoffmann, T.K.; Plinkert, P.K.; Koffler, J.; Heß, J. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Five‐Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study. Issue 1 (17th December 2014) Authors: Budde, K.; Lehner, F.; Sommerer, C.; Reinke, P.; Arns, W.; Eisenberger, U.; Wüthrich, R. P.; Mühlfeld, A.; Heller, K.; Porstner, M.; Veit, J.; Paulus, E.‐M.; Witzke, O.; on behalf of the ZEUS Study Investigators Journal: American journal of transplantation Issue: Volume 15:Issue 1(2015:Jan.) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0299 Real world secukinumab study in as and psa – comorbidities and extraarticular manifestations: incidence and status throughout non-interventional aquila study in germany. (12th June 2018) Authors: Kiltz, U.; Kästner, P.; Krauel, H.; Schwarze, I.; Brandt-Jürgens, J.; Maier-Peuschel, M.; Legeler, C.; Veit, J.; Tony, H.-P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗